Professional Documents
Culture Documents
S P OT L I G H T
Hemp Cultivation
Savills Research
in the UK
£500
For one tonne of hemp
7.5
Potential hemp fibre yield
600m
Average annual rainfall
seeds before processing in tonnes per hectare needed to grow hemp
Once an essential fibre, hemp had all but disappeared Both hemp oil and CBD oil
can be derived from any
from UK markets by the end of the 20th century cannabis plant. They are
both non-psychoactive
Hemp has been cultivated and used in the UK for Obtaining a licence
with acceptable levels of
centuries for its biomaterial properties – in fact its Cultivating industrial hemp constitutes a “special THC. But there are some
long fibres have been spun and woven to make sails, purpose” under the Misuse of Drugs Act 1971 (MDA), crucial differences.
rigging and ropes for ships since before the Elizabethan meaning it is permitted once a licence is obtained.
era. Now it is making a comeback for very different There is a wide range of varieties that can be grown HEMP OIL
reasons. Here we explain the background to its rapid and careful attention should be paid to their individual Obtained from cold
evolution and offer guidance for UK farmers looking characteristics to select the most appropriate seed. pressed seeds that
to access the market. The variety chosen should also comply with the UK contain low volumes of
cannabinoids. Hemp oil
definition of industrial hemp by containing no more
often does not contain
Multiple end uses than 0.2% tetrahydrocannabinol (THC). Knowing this
CBD but does possess a
As a quick growing plant, hemp can rapidly accumulate and other traits that are specific to the local climate mix of nutrients, protein
biomass and so sequester carbon dioxide in the and soils, means that growers can tailor their crop to and fats. It can be used
process. Once grown, hemp fibres can be used to create the law and their business plan. For example, in food supplements,
products ranging from paper and building materials harvesting seeds for oil extraction requires a shorter- cooking oils and body
to bioplastics and livestock bedding. If the plant is stem crop for the combine harvester. care products.
allowed to mature and produce seeds, additional Only the fibre and seed can be used under an
products can be manufactured, including hemp oil for industrial hemp licence. These elements contain CBD OIL
cooking and seed cake for animal feed. the lowest levels of THC and cannabidiol (CBD). Obtained from the leaves,
flowers and stalks of the
Hemp has received significant attention for its Growers looking to produce cannabis for high value
cannabis plant using
ability to capture carbon and form part of circular cannabinoids should therefore look to the medicinal
solvent extraction
systems. Such systems aim to eliminate waste and cannabis licence. Nonetheless, industrial hemp methods, CBD oil should
continuously reuse and recycle resources. Depending offers numerous benefits for growers, as well as an contain pure CBD and no
on the final use of the plant, this carbon can potentially opportunity for healthy returns. The industrial hemp other cannabinoids.
be stored indefinitely. So called hempcrete is being licence is far more accessible, with less regulation and Perceived wellbeing
praised for its ability to both offset a carbon-intensive a lower cost of £580 for a new, three-year licence. benefits and greater
building material and simultaneously provide a long public awareness has
term carbon store. Alternatively, it is a natural fibre resulted in rapid market
growth of CBD products.
that is biodegradable and can potentially replace
synthetic fibres.
Its environmental credentials also extend to soil
health. Having a large taproot, hemp can not only
reduce soil compaction but also recover nutrients
ordinarily outside of the root zone that may otherwise
leach into the groundwater and be lost. If correctly
deployed into a rotation, it offers a unique variation
in crop type and is also believed to shade out weeds.
Both of these factors lead to a reduced requirement
for pest control.
Supplements
Cannabis sativa
Paper
Industrial
Hempcrete
Medicinal Body care 0.2%
hemp cannabis products
If the THC content
Insulation Clothing Sativex
is below this, the
(multiple
sclerosis)
plant is classified
Cooking oil Epidiolex
(epilepsy) Source Savills Research as industrial hemp
savills.com/research 2
Market evolution
3
Medicinal cannabis
Global legal medicinal cannabis production The UK has emerged as a world leader
2008
UK
2009
Canada
2010
Israel
2011
Other
2012
Total
Year
2013
2014*
2015
2016
2017
savills.com/research 4
CBD production
500%
Increase in UK production
235
Tonnes of cannabis derived
250k
Number of CBD oil
between 2015 and 2017 medicines produced by UK users in the UK in 2018
1
as a medicine and food ingredient are analysed did not contain the CBD Tetrahydrocannabinol (THC)
likely to have contributed, as well as the content indicated on the product produces the psychoactive
increased awareness among the public labels. Others were found to have effects that cannabis is
of its perceived wellbeing benefits. unacceptable levels of controlled synonymous with. As the
The market is currently worth £300 substances, such as THC. Many principal psychoactive
compound, THC is responsible for
million in the UK, a figure that producers are, therefore, turning
the “high” that cannabis can produce,
is expected to more than triple in to self-regulation and independent
as well as its medicinal properties.
the next five years. That equates to verification to ensure compliance and Unsurprisingly, it is this compound
a £1 billion market in CBD alone by a quality product. that is most closely regulated.
2025. The number of CBD oil users Extraction of cannabidiol
2
also doubled from 125,000 to 250,000 compounds is highly regulated, Cannabidiol (CBD)
between 2017 and 2018. High street meaning such markets are largely is the compound providing
chains such as Holland & Barrett, Boots inaccessible. Yet this makes the UK an cannabis with its recent
and Lloyds Pharmacy are all stocking attractive prospect for those capable of market success in the UK.
CBD products as they provide the most overcoming regulatory barriers, owing The compound is not
psychoactive, but many people believe
accessible products for both producers to the reduced competition in this
it has numerous wellbeing benefits.
and consumers. country. Those who obtain a licence
While not producing a “high”, CBD
All CBD oils incorporated into high to extract and utilise cannabidiol has been linked with pain relief and
street products are imported into the compounds for medicinal or scientific reduced feelings of anxiety. CBD
UK, predominantly from the US and purposes are few and far between and is not regulated like THC and greater
Eastern Europe. It is questionable so the production is likely to be a high awareness of these perceived benefits
whether all these imports go through value product. has led to this growing market.
5
The world market
$228m 33
Predicted value of CBD Numer of US states where
2013
Year recreational cannabis
sales in China in 2020 medicinal cannabis is legal use was legalised in Uruguay
International opportunities
Attitudes to the growth and use of hemp and cannabis vary around the
world, which in turn is reflected in international legislation and world trade
Europe South America production volumes and a high quality seed
With a combined population of nearly Uruguay often steals the South American bank, it is well positioned to be a global leader.
750 million, Europe could potentially offer spotlight when it comes to cannabis, Indeed, the lack of restriction on production
a larger market than North America. being the first nation in the world to fully volumes explains why this small nation is one
Momentum is also building with more nations legalise recreational use of cannabis in 2013. of the largest exporters at present (generally
within the bloc permitting some kind of Despite this, production in the region is not only outdone by Canada and the UK).
medicinal use. particularly high. Yet it could eventually
Germany has been widely hailed as a rival North America and Europe with ideal Oceania
progressive leader in the area, with a broad conditions, large areas of arable land and Australia legalised cannabis for medicinal use
list of qualifying conditions leading to a cheaper labour costs. in 2016 and is the production and distribution
marked increase in registered patients. It is hub for the Asia Pacific region. The medicinal
also the first nation in the world to cover the Asia and the Middle East market remains highly regulated however,
cost of medicinal cannabis. China grows nearly half the world’s legal as indicated by a relatively low number of
Europe is a continent of contradictions. hemp, with sales in 2018 totalling $1.2 billion. registered patients.
France, despite legalising cannabis for Unlike the UK, leaves and flowers may be Cultivation and production is permitted
medicinal use in 2013, has so far not seen processed for CBD leading to a burgeoning under licence and exports are also allowed
a single patient use any form of cannabis market. Sales of CBD are predicted to reach providing regulations are met and domestic
based drug. $228 million this year, quadruple what it was supply is not affected. Australia already has
only a year ago. The nation is not entirely an established pharmaceutical brand in the
North America permissive and the anti-drugs squad declared region, which means there is significant
Canada became the first G-7 nation to legalise that China has never approved industrial potential for growth.
recreational cannabis use in 2018. Since then, cannabis as a medical or food additive. Tighter In New Zealand, medicinal cannabis can
innovation and investors have flowed into the monitoring is expected in the future, coupled be prescribed through special permits or
market. Eleven US States legalised recreational with wider application of by-products. licences but only for defined conditions and
use before Canada, but it ultimately remains Israel has been a leader in medicinal at personal expense. Recreational use is
prohibited at a federal level. Medicinal use is cannabis research for a number of decades. currently illegal, though that could change
permitted in a further 33 states. With an ideal climate, no restriction on following a referendum in 2021.
savills.com/research 6
Things to know
1 2
Two separate opportunities Invest in expertise
It should now be clear that hemp and Whether growing hemp or cannabis
cannabis, despite belonging to the same indoors or outdoors establishing the
family, are two very distinct crops that enterprise can be complex both from Outdoor
require entirely separate approaches. a regulatory and practical perspective.
This disparity will mean the correct direction
for your business is already determined.
For the average farming business, the capital
Outdoor
Poor siting and care can lead to diminished yields,
while falling foul of regulations can lead to whole
crops being destroyed.
Greenhouse
intensive and highly regulated cannabis regime Seeking advice from specialist consultants can,
may well be unobtainable. Such undertakings are therefore, prove invaluable in both instances until
only possible for companies with significant experience and expertise in the sector is acquired.
capital and expertise available to invest. Such expertise is often an easier pathway into
In contrast, growing hemp represents a niche the wider network of producers, manufacturers
opportunity for farmers to diversify. Besides and distributors that are key to success. This is
providing reduced exposure to risk and also particularly the case for medicinal grade cannabis
opportunity for enhanced returns, hemp may well where partnerships are essential from the very
Greenhouse
bring other benefits. Improved soil health, carbon beginning of the process.
3
sequestration and reduced nutrient loss are all
Capital a
possibilities that are increasingly well regarded Keeping costs down
by both regulators and the public. To achieve a premium-grade cannabis
Outdoor Greenhouse
product, a high capital controlled
environment system is needed. It is
Indoor
the only method for growing high
THC medicinal cannabis, which can attract
Seeds
greater returns.
These costs are dominated by utility bills for
the lighting, heating and water pumping that
are necessary to maintain optimum growing
Manufa
and carbon dioxide, such as an anaerobic digestion
plant, an internet server or a boiler room in a
commercial property, can be advantageous and
Seeds Utilities
also help to minimise costs.
Given the sensitive nature of the crop, security ● Capital and infrastructure
procedures will also need to be considered. ● Labour
Controlled cultivation methods have improved ● Seeds
Capital and infrastructure Labour
Manufacture
security because the buildings themselves count ● Utilities
as an obstacle in themselves, but this alone will ● Nutrients
not be adequate. Measures such as fencing, ● Manufacture
CCTV and alarms will be required for any site
Seeds
to obtain a licence.
Utilities Nutrients
Source Deloitte
Manufacture
Outlook and opportunities
The versatility of hemp has been well known for generations and its use as an alternative to
plastic will be of increasing interest. Growing acceptance of its medicinal usage increases the
scope for further market development. Increased cultivation will improve the affordability of
$66.3bn
cannabis-based medications and likely expand their use and the research around them. Even The predicted value
without recreational use, the cannabis market is ripe for investment. Potential investors should
carefully consider which of the many end-markets they will focus on. Once such a business
of the global cannabis
plan is in place, significant returns on investment are certainly possible. market by 2025
7
Savills Research
We’re a dedicated team with an unrivalled reputation for producing well-informed and
accurate analysis, research and commentary across all sectors of the UK property market.
Savills plc: Savills plc is a global real estate services provider listed on the London Stock Exchange. We have an international network of more than 600 offices and associates throughout the Americas, the UK,
continental Europe, Asia Pacific, Africa and the Middle East, offering a broad range of specialist advisory, management and transactional services to clients all over the world. This report is for general informative
purposes only. It may not be published, reproduced or quoted in part or in whole, nor may it be used as a basis for any contract, prospectus, agreement or other document without prior consent. While every effort has
been made to ensure its accuracy, Savills accepts no liability whatsoever for any direct or consequential loss arising from its use. The content is strictly copyright and reproduction of the whole or part of it in any form
is prohibited without written permission from Savills Research.